Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cel save search
Atara Biotherapeutics Announces Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories and Third Quarter 2023 Financial Results
Published: 2023-11-01 (Crawled : 15:00) - biospace.com/
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: 3.1%
H: 0.75%
C: -5.26%
cel partnership global financial results
Atara Biotherapeutics Announces Plans to Submit Tab-cel® BLA in Q2 2024 Following FDA Agreement on Comparability
Published: 2023-09-19 (Crawled : 21:00) - biospace.com/
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: 0.0%
H: 3.21%
C: 1.28%
cel fda agreement
Atara Biotherapeutics Presents Updated Tab-cel® Clinical Effectiveness Data at ASCO 2023
Published: 2023-06-05 (Crawled : 14:00) - biospace.com/
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: 0.0%
H: 2.92%
C: 1.3%
cel asco
Atara Biotherapeutics Presents Updated Clinical Data from Pivotal Phase 3 Trial (ALLELE) of Tab-cel® at the 64th American Society of Hematology (ASH) Annual Meeting
Published: 2022-12-12 (Crawled : 18:00) - biospace.com/
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: -0.67%
H: 1.47%
C: -2.26%
cel meeting trial
Atara Biotherapeutics to Receive Additional Near-Term Milestone Payment Under Updated Tabelecleucel (Tab-cel®) Commercialization Agreement with Pierre Fabre
Published: 2022-09-28 (Crawled : 22:00) - biospace.com/
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: 2.7%
H: 14.62%
C: 12.28%
cel commercialization payment agreement milestone
The International Society for CNS Drug Development (ISCDD) Celebrates 20th Annual Meeting Anniversary
Published: 2022-03-21 (Crawled : 14:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.25%
H: 0.0%
C: 0.0%
drug cel international tiona
Ketchum and Its Clients Celebrate Four PRWeek Award Wins, More Than Any Other Agency
Published: 2022-03-21 (Crawled : 13:30) - omnicomgroup.com
OMC | $92.62 1.22% 0.0% 2.4M
|
Commercial Services
|
| O: -0.07%
H: 1.27%
C: -0.44%
cel
Supermicro's SuperBlade, Twin and Ultra Server Families Powered by 3rd Gen AMD EPYC™ Processors with 3D V-Cache™ Technology Accelerate Critical Product Design and Key Technical Computing Workloads
Published: 2022-03-21 (Crawled : 13:30) - prnewswire.com
SMCI | $714.04 -23.1% -30.25% 17M
|
Electronic Technology
|
| O: -0.82%
H: 2.39%
C: 1.06%
AMD | $146.54 -5.51% -5.83% 71M
|
Electronic Technology
|
| O: 0.24%
H: 3.38%
C: 1.93%
technology cel work designation
Lineage Announces Pipeline Expansion to Include Auditory Neuronal Cell Therapy for Treatment of Hearing Loss
Published: 2022-03-21 (Crawled : 13:30) - biospace.com/
LCTX | $1.15 -4.17% 0.0% 1.1M
|
Health Technology
|
| O: 2.13%
H: 0.0%
C: -5.56%
treatment expansion cel therapy hearing loss
Cellectar Reports Financial Results for Year Ended December 2021 and Provides a Corporate Update
Published: 2022-03-21 (Crawled : 13:00) - globenewswire.com
CLRB | $3.02 -0.66% -0.66% 810K
|
Health Technology
|
| O: 11.11%
H: 8.35%
C: 4.23%
financial results cel report results
Compugen's Computational Discovery Leverages Single Cell Spatial Transcriptomics to Gain In-Depth Understanding of the Tumor Microenvironment
Published: 2022-03-21 (Crawled : 12:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: -0.91%
H: 1.54%
C: -2.77%
cel computational tiona
SQZ Biotechnologies Announces $2 Million Grant From the National Institutes of Health to Develop a Novel, Scalable Cell Replacement Therapy for Parkinson’s Disease
Published: 2022-03-21 (Crawled : 12:00) - biospace.com/
SQZ | $0.435 0.0% 30M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -4.23%
health 2 million parkinson disease cel sqz therapy biotech iot tiona grant
Combining Microbubbles & Cell Sorting for Quick & Efficient Cell Isolation
Published: 2022-03-19 (Crawled : 00:20) - thermogenesis.com
THMO | $0.6695 3.0% 2.91% 8.6K
|
Health Technology
| Email alert
Add to watchlist
cel
DEADLINE: Celsius Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - CELH
Published: 2022-03-19 (Crawled : 00:20) - prnewswire.com
CELH | $68.84 -1.62% -1.64% 3.5M
|
Consumer Non-Durables
| Email alert
Add to watchlist
cel deadline
Luxury Furniture Market In APAC Accelerates at 5.38% CAGR | 17,000+ Technavio Research Reports
Published: 2022-03-19 (Crawled : 04:20) - prnewswire.com
ALC | $79.55 1.38% -0.25% 1.1M
|
Health Technology
| Email alert
Add to watchlist
research cel report
Piedmont Natural Gas celebrates its employees on Natural Gas Utility Workers' Day
Published: 2022-03-18 (Crawled : 20:00) - prnewswire.com
DUK | News | $98.24 2.41% 0.0% 4.1M
|
Utilities
| Email alert
Add to watchlist
day natural gas cel work
HII Celebrates Centennial of U.S. Navy Aircraft Carriers
Published: 2022-03-18 (Crawled : 15:00) - globenewswire.com
HII | $271.66 1.05% 0.0% 350K
|
Electronic Technology
|
| O: -0.17%
H: 0.46%
C: -1.68%
air cel
Combined Heat and Power (CHP) Market to accelerate at 6.57% CAGR | USD 8.35 Bn incremental growth expected during the forecast period | Technavio
Published: 2022-03-18 (Crawled : 11:00) - prnewswire.com
ABLZF | News | $48.065 -32.74% 4.7K
|
Producer Manufacturing
|
| O: 4.52%
H: 2.54%
C: 2.52%
CGRN | $0.37 -18.49% 1.8M
|
Manufacturing
|
| O: 0.26%
H: 8.18%
C: 3.96%
CMI | $287.56 -1.33% 0.0% 2.6M
|
Producer Manufacturing
|
| O: -1.43%
H: 2.28%
C: 2.11%
ABB | News | $37.13 -0.03% 6.4M
|
Producer Manufacturing
|
| O: 0.17%
H: 0.0%
C: 0.0%
creme cel growth
Oncolytics Biotech® Announces Publication of Preclinical and Patient Data Demonstrating Pelareorep's Stimulation of Natural Killer Cell Anti-Cancer Activity
Published: 2022-03-17 (Crawled : 19:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 3.95%
H: 5.7%
C: 2.53%
biotech cel preclinical cancer iot pre-clinical
Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Disease-Free Survival (DFS) Versus Placebo as Adjuvant Therapy in Patients With Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) Regardless of PD-L1 Expression
Published: 2022-03-17 (Crawled : 19:00) - biospace.com/
MRK | News | $125.78 0.44% 0.0% 8.4M
|
Health Technology
|
| O: 0.04%
H: 1.56%
C: 1.01%
keytruda disease cel lung cancer therapy cancer
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.